Janux Therapeutics JANX EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Janux Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Janux Therapeutics's EV / sales?
- Janux Therapeutics (JANX) reported EV / sales of 59.4× in Q1 2026.
- How has Janux Therapeutics's EV / sales changed year-over-year?
- Janux Therapeutics's EV / sales decreased by 64.1% year-over-year, from 165.5× to 59.4×.
- What is the long-term trend for Janux Therapeutics's EV / sales?
- Over 4 years (2021 to 2025), Janux Therapeutics's EV / sales has grown at a -21.8% compound annual growth rate (CAGR), from 214.4× to 80×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.